8
Oct
2024

PENMIX Co. Ltd.

Exhibitor at CPHI Milan 2024 stand 5C106, Contract Manufacturing and Services
About Us

Penmix has been a leading contract manufacturer of penicillin since 2002 with well-established reputation. We provide all types of penicillin finished dosage forms in compliance with GMP, and export to mainly Japan with sales revenue of 15 million and other Asian countries. With our abundant experiences as contract manufacturer, we are now looking for entering into global market with newly established General Injectable lines (lyophilized, pre-filled and solution) that has been operated since end of 2013. Penmix has desire to closely work with ...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • KR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
CMO/CDMO
Contract Service
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • 82-2-2175-9848
  • Ohsong Blgd, 14 Jeongdong-gil, , 100-120, Jung-gu, Seoul, Korea, Republic Of
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 5C106, Contract Manufacturing and Services

Products Featured at CPHI Milan 2024

  • Daptomycin

    Product Daptomycin

    For treatment of bloodstream infection (bacteremia) associated with right infective endocarditis caused by Staphylococcus aureus(including methicillin sensitivity and methicillin resistance). 
  • Ferric Carboxymaltose

    Product Ferric Carboxymaltose

    Under development for global market
  • Sugammadex

    Product Sugammadex

    200mg/2mL500mg/5mL